Hope rises out of despair: bedaquiline and linezolid for the treatment of drug-resistant TB

Int J Tuberc Lung Dis. 2020 Oct 1;24(10):987-988. doi: 10.5588/ijtld.20.0379.

Authors

J Furin¹, O W Akkerman²

Affiliations

¹ Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA, USA.
² Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands, Tuberculosis Center Beatrixoord, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands, <email></email>, Email: jennifer_furin@hms.harvard.edu.

PMID: 33126928
DOI: 10.5588/ijtld.20.0379

No abstract available

Publication types

Editorial
Comment

MeSH terms

Coinfection
Diarylquinolines* / therapeutic use
HIV Infections
Humans
Linezolid* / therapeutic use
Treatment Outcome
Tuberculosis* / drug therapy

Substances

bedaquiline
Diarylquinolines
Linezolid